| Literature DB >> 31489614 |
Blandine Dozières-Puyravel1, Hala Nasser1, Monique Elmaleh-Bergès1, Elisa Lopez Hernandez1, Antoinette Gelot2, Adina Ilea1, Catherine Delanoë1, Jean-Philippe Puech3, Catherine Caillaud3, Samia Pichard1, Stéphane Auvin1.
Abstract
Neuronal ceroid lipofuscinoses (NCLs) are rare, progressive disorders. Through this series of 20 patients with NCL, we illustrate differences between subtypes in their presenting symptoms and clinical, imaging, and electrophysiological results to raise awareness of symptom diversity. Data were available on presenting symptoms, genetics, magnetic resonance imaging (MRI), electroencephalography (including with low-frequency intermittent photic stimulation), visual responses, and electron microscopy. Causal mutations were identified in 10 patients. Eleven patients had neuronal ceroid lipofuscinosis type 2 (CLN2) disease and their most common presenting symptom was seizures, although motor and language defects were also reported. Five patients with CLN2 disease showed abnormalities at initial MRI, but only three showed a photic response with low-frequency stimulation. Seizures were not as common a presenting symptom in other NCL subtypes. Patients with NCLs present with diverse symptoms, which may not be characteristic in early disease stages. These signs and symptoms should lead to rapid diagnostic confirmatory testing for NCLs. WHAT THIS PAPER ADDS: Disease presentation is not uniform for neuronal ceroid lipofuscinoses. Characteristic clinical test results may not be identified in early disease stages.Entities:
Mesh:
Year: 2019 PMID: 31489614 DOI: 10.1111/dmcn.14346
Source DB: PubMed Journal: Dev Med Child Neurol ISSN: 0012-1622 Impact factor: 5.449